Nose Spray Anthrax Vaccine Effective In Early Tests
Published: Apr 14, 2008
ScienceDaily (Apr. 12, 2008) — Early studies show that a new mucosal vaccine against anthrax has the potential to provide military personnel with more effective and efficient protection against a “popular” bioweapon, according to a study published in the journal Clinical and Vaccine Immunology (CVI). With the new vaccine, researchers sought to take two steps at once, fine-tuning its ingredients and delivering it by nose spray instead of injection.